Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients

Fenretinide (HPR) is a synthetic retinoid which has been shown to cause a reduction in the incidence of carcinogen-induced epithelial tumors in experimental animals, and it has been chosen to be tested as a chemopreventive agent in humans. A study on plasma concentrations of HPR, of its metabolite N...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 1989-11, Vol.49 (21), p.6149
Hauptverfasser:	Formelli, F, Carsana, R, Costa, A, Buranelli, F, Campa, T, Dossena, G, Magni, A, Pizzichetta, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Breast Neoplasms - blood Breast Neoplasms - drug therapy Drug Administration Schedule Drug Evaluation Female Fenretinide Follow-Up Studies Humans Tretinoin - adverse effects Tretinoin - analogs & derivatives Tretinoin - blood Tretinoin - therapeutic use Vitamin A - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!